[1]安小平,崔庆荣,康学东.苦瓜胶囊治疗2型糖尿病胰岛素抵抗的临床观察[J].西部中医药,2017,30(03):1-4.
　AN Xiaoping,CUI Qingrong,KANG Xuedong.Clinical Observation on Function of KuGua Capsule for Improving Insulin Resistance in Patients with Type Two Diabetes Mellitus[J].Western Journal of Traditional Chinese Medicine,2017,30(03):1-4.
点击复制

苦瓜胶囊治疗2型糖尿病胰岛素抵抗的临床观察()
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
30
期数:
2017年03期
页码:
1-4
栏目:
出版日期:
2017-03-15

文章信息/Info

Title:
Clinical Observation on Function of KuGua Capsule for Improving Insulin Resistance in Patients with Type Two Diabetes Mellitus
文章编号:
1004-6852(2017)03-0001-04
作者:
安小平，崔庆荣，康学东
甘肃中医药大学附属医院，甘肃 兰州 730000
Author(s):
AN Xiaoping, CUI Qingrong, KANG Xuedong
Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China
关键词:
2型糖尿病; 胰岛素抵抗; 苦瓜胶囊; 治疗; 临床研究性
Keywords:
type two diabetes mellitus;  insulin resistance;  KuGua capsule;  treatment
分类号:
R259
文献标志码:
A
摘要:
目的：观察苦瓜胶囊联合西药治疗2型糖尿病胰岛素抵抗的临床疗效。方法：将2型糖尿病患者86例按随机、单盲原则分为治疗组、对照组各43例；治疗组在西药治疗的同时加服苦瓜胶囊，对照组予单纯西药治疗，疗程为14周。观察2组患者糖化血红蛋白(HbA1c)、胰岛素抵抗指数(HOMA-IR)、胰岛素分泌指数(HOMA-β)、糖负荷后30分钟胰岛素净增值/葡萄糖净增值(△I30/△G30)。结果：1)2组患者治疗后HbA1c、血糖较治疗前均明显改善(P＜0.05)，2组治疗后比较差异有统计学意义(P＜0.05)；2)2组患者治疗后空腹胰岛素、C肽及服糖后30分钟胰岛素、C肽较治疗前均明显改善(P＜0.05)，2组治疗后比较差异有统计学意义(P＜0.05)；3)2组患者治疗后HOMA-IR、HOMA-β、糖负荷后30分钟△I30/△G30较治疗前均明显改善(P＜0.05)，2组治疗后比较差异有统计学意义(P＜0.05)；4)2组患者治疗后总胆固醇（TC）、甘油三酯（TG）、脂联素(APN)较治疗前均明显改善，且治疗组在改善TG、APN方面优于对照组(P＜0.05)。结论：苦瓜胶囊联合西药改善2型糖尿病患者胰岛素抵抗的疗效优于单纯西药。
Abstract:
Objective: To observe the clinical effect of combination of KuGua(Momordica Charantia L.) capsule and western medicine for improving insulin resistance in patients with type two diabetes mellitus(T2DM). Methods: All 86 patients with T2DM were divided into the treatment group and the control group based on randomized and single blind principle, and 43 cases in each group. The treatment group was treated with western medicine and KuGua capsule at the same time, the control group was only treated with western medicine, and the treatment courses of both groups were 14 weeks. glycosylated hemoglobin(HbA1c), insulin resistance index (HOMA-IR), insulin secretion index (HOMA-β), and the ratio of insulin net added value after 30min of glucose load with glucose net added value(△I30/△G30) of two groups were observed. Results: 1) HbA1c and glucose levels of patients in two groups improved significantly before and after the treatment (P＜0.05), and the differences were statistically significant(P＜0.05); 2) The levels of fasting insulin, C peptide, insulin and C peptide in 30min after taking glucose of the patients in two groups all improved significantly before and after treatment, and the differences between two groups were statistically significant(P＜0.05); 3) HOMA-IR, HOMA-β and the ratio of insulin net added value after 30min of glucose load with glucose net added value(△I30/△G30) of patients in two groups all improved significantly before and after treatment, and the differences between two groups were statistically significant (P＜0.05); 4) TC, TG and APN of patients in two groups all improved significantly before and after treatment, and in the aspect of TG and APN improvement, the treatment group was better than the control group(P＜0.05). Conclusion: The effect of the combination of KuGua capsule and western medicine for improving insulin resistance in patients with T2DM is better than that of western medicine only.

相似文献/References:

[1]潘文,王贵霞,王晓萍.多囊卵巢综合征伴胰岛素抵抗的发病机制研究及中药干预作用[J].西部中医药,2012,25(12):121.
　PAN Wen,WANG Gui-xia,WANG Xiao-ping.Study on Pathogenesis of Polycystic Ovary Syndrome Complicated with Insulin Resistance and Intervention with Traditional Chinese Medicine[J].Western Journal of Traditional Chinese Medicine,2012,25(03):121.
[2]祁瑞芳.同型半胱氨酸、超敏 C- 反应蛋白在 2 型糖尿病合并脑梗死预测中的作用[J].西部中医药,2014,27(08):152.
[3]邱勇玉,李应东,赵信科,等.高血压病中医证型与 2 型糖尿病及其相关危险因素分析[J].西部中医药,2014,27(09):75.
[4]李东峰,指导：王志刚.王志刚主任医师治疗2型糖尿病“三级”防治思想辨治心得[J].西部中医药,2015,28(01):29.
[5]杨国军.黄芪注射液对2型糖尿病患者血管功能及微循环状态的影响[J].西部中医药,2015,28(05):109.
[6]杨维杰,康学东△,朱瑾,等.解毒化浊方对胰岛素抵抗大鼠GLUT4 mRNA表达的影响[J].西部中医药,2015,28(07):8.
[7]张喜芬,赵保礼,杨立波,等.通络明目胶囊治疗糖尿病视网膜病变的随机双盲对照研究[J].西部中医药,2013,26(11):88.
　ZHANG Xifen,ZHAO Baoli,YANG Libo,et al.A Randomized, Double-blind and Placebo-controlled Study of TongLuo MingMu Capsule in Treating Diabetic Retinopathy[J].Western Journal of Traditional Chinese Medicine,2013,26(03):88.
[8]戴梅.全面干预护理对2型糖尿病患者血糖和糖化血红蛋白水平的影响[J].西部中医药,2013,26(07):109.
　DAI Mei.Intervention of Comprehensive Nursing on Blood Glucose and Glycosylated Hemoglobin of Patients with Diabetes Mellitus Type Two[J].Western Journal of Traditional Chinese Medicine,2013,26(03):109.
[9]张家林,裴瑞霞.银花痛风颗粒治疗2型糖尿病合并高尿酸血症疗效观察[J].西部中医药,2014,27(01):106.
　ZHANG Jialin,PEI Ruixia.Clinical Observation on YinHua TongFeng Granules in Treating Type 2 Diabetes Mellitus Complicated with Hyperuricemia[J].Western Journal of Traditional Chinese Medicine,2014,27(03):106.
[10]祁瑞芳.同型半胱氨酸、超敏C-反应蛋白在2型糖尿病合并脑梗死预测中的作用[J].西部中医药,2014,27(04):136.
　QI Ruifang.Diagnostic Value of Homocysteine and High Sensitivity C-Reactive Protein in Predicting Type 2 Diabetes Mellitus Complicated with Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2014,27(03):136.
[11]周雨聪,指导：刘召.红灵五黄汤治疗2型糖尿病90例[J].西部中医药,2015,28(04):99.
[12]康学东,张瀚文.病证结合探讨2型糖尿病胰岛素抵抗[J].西部中医药,2015,28(11):112.
[13]秦灵灵,穆晓红,徐暾海,等.匙羹藤总皂苷对2型糖尿病小鼠脂肪组织GLUT4的调控作用[J].西部中医药,2019,32(05):16.
　QIN Lingling,MU Xiaohong,XU Tunhai,et al.The Effects of Total Saponins of Gymnema Sylvestre on the Regulation of Adipose Tissue GLUT4 of T2DM Mice[J].Western Journal of Traditional Chinese Medicine,2019,32(03):16.
[14]王文婷,郭良清.七味白术散通过调控肠道菌群改善2型糖尿病胰岛素抵抗的理论探讨[J].西部中医药,2022,35(06):56.[doi:10.12174/j.issn.2096-9600.2022.06.15]
　WANG Wenting,GUO Liangqing.Discussion on the Theory of Qiwei Baizhu Powder Improving Insulin Resistance in Type Two Diabetes Mellitus by Regulating Intestinal Flora[J].Western Journal of Traditional Chinese Medicine,2022,35(03):56.[doi:10.12174/j.issn.2096-9600.2022.06.15]
[15]郭胜男,张莉,吴深涛,等.典型黄酮类化合物改善胰岛素抵抗研究进展[J].西部中医药,2022,35(11):144.[doi:10.12174/j.issn.2096-9600.2022.11.30]
　GUO Shengnan,ZHANG Li,WU Shentao,et al.Research Progress of Typical Flavonoids Improving Insulin Resistance[J].Western Journal of Traditional Chinese Medicine,2022,35(03):144.[doi:10.12174/j.issn.2096-9600.2022.11.30]

备注/Memo

备注/Memo:
收稿日期：2016-08-14*基金项目：2011年甘肃省中医药管理局科研项目(编号GZK-2011-25)。作者简介：安小平(1981—)，女，硕士学位，主治医师。研究方向：糖尿病及其并发症的中西医结合治疗。
更新日期/Last Update: 2017-03-15